Pulsómetro AXN300 negro

http://www.librosdecardiologia.com/

Fabricante: Polar

Ref: PLAXN30000
Disponibilidad: 3 días
Precio: 163,75 € (176,85€ iva incluído)
 

 

 

 

 

 

 

 

 

 

 

 

http://www.libreriasaulamedica.com/ficha.asp?id=91095&titulo=Pulsometro--AXN300-negro&isbn=

 

 

 

 

 

Pulsómetro Polar AXN300 Negro está diseñado para cubrir las necesidades de los diferentes entusiastas de los deportes outdoor: carrera en ruta o montaña, alpinistas y montañistas, esquiadores y ciclistas de montaña, piragüistas y rafters, escursionistas, trekers, y corredores de aventura.

Pulsómetro Polar multideporte . ¿te apasiona ponerte a prueba? Con el Polar AXN300 podrás llevar la cuenta de tus descensos, comprobar tu ritmo al bajar por una pista o al subir por las rocas, estar preparado para los cambios de tiempo, y controlar tu gasto de energía además por supuesto de medir tus pulso.

Función cardío

·Ritmo Cardíaco en continuo, precisión ECG
·RC en latidos por minuto o en % del RC max
·Grafo del RC
·Transmisor codificado T 31
·Own Code: transmisión codificada del RC
·Una zona objetivo con alarme
·Own Cal: control de peso (cal)
·Tasa de consumo de calorías (kcal/h)
·Own Index: índice semejante al VO2max

Función Altímetra

·Altitud instantánea
·Grafo de altitud
·Desnivel positivo y negativo
·Velocidad vertical
·Monitor de pendiente

Función barométrica

·Presión atmosférica/mar
·Presión atmosférica absoluta
·Grafo presión atmosférica
·Temperatura

Función reloj

·Hora, fecha, 2 husos horarios.
·3 alarmas, 5 recordatorios.
·Cronómetro y cuenta hacia atrás.
·Anuncio pantalla amplia, con iluminancia.
·Hermético hasta los 100 m
·Pila intercambiable por el usuario (receptor)

Funciones de conexión al ordenador

Up Link: una función que permite cargar configuraciones de ejercicios e icono de monitor desde el sitio web de Polar o desde el Software Polar Precisión Performance 3.0

80 archivos memoria

Autolog (memoria circular): 1 semana.

Coronary Heart Disease: Clinical, Pathological, Imaging, And Molecular Profiles

http://www.librosdecardiologia.com/

Edición: 1ª
Autores: Daniel J. Garry; Robert F. Wilson; Zeev Vlodaver
Editorial: Springer
ISBN: 9781461414742
Formato: Rústica/Paperback
Nº volumenes: 1 Páginas: 540
Año publicación: 2012
Disponibilidad: 15 días
Precio: 179,95 € (187,15€ iva incluído)

http://www.libreriasaulamedica.com/Coronary-Heart-Disease-Clinical-Pathological-Imaging-And-Molecular-Profiles_9781461414742_93618





ABOUT THIS BOOK
■Comprehensive volume on ischemic heart disease
■Includes cardiovascular imaging, research, pathology and clinical cardiology
■Correlations of information from cases including clinical, pathological and imaging studies
Coronary Heart Disease: Clinical, Pathological, Imaging, and Molecular Profiles presents a comprehensive picture of ischemic heart disease for practitioners, students, and investigators dealing with the varied facets of this complex subject. Individual chapters introduce the anatomy of the coronary blood vessels and cardiac development, while others consider current imaging modalities utilized for ischemic heart disease, including stress echo, nuclear diagnostic tests, non-invasive coronary artery imaging, and coronary angiography. Imaging chapters provide key clinical information on techniques and indications, and include examples of both normal and abnormal patterns.

The principle thrust of the book concerns coronary atherosclerosis, the pathology of which is presented in conjunction with the results of anatomic, non-invasive imaging and angiographic studies. Related chapters cover atherogenesis, presenting new insights into the pathophysiology of the vulnerable plaque, the role of progenitor cells in vascular injury, inflammation and atherogenesis, and the genomics of vascular remodeling. Additional topics covered include angina pectoris, acute coronary syndromes, healed myocardial infarction and congestive heart failure, catheter-based and surgical revascularization, and surgical treatment of myocardial infarction and its sequelae.

With contributions from a diverse group of internationally-known physicians with broad experience in the diagnosis and treatment of coronary heart disease, this book will be a valuable resource for practitioners in clinical cardiology, thoracic surgery, pathology, and cardiovascular molecular research, as well as for students in training.

Content Level » Professional/practitioner
Keywords » coronary imaging - heart disease - molecular profiles - pathology
Related subjects » Cardiology & Angiology

TABLE OF CONTENTS
■Anatomy of Coronary Vessels.
■Cardiac Development.
■Echocardiographic Evaluation of Ischemic Heart Disease.
■Nuclear Imaging in Ischemic Heart Disease.
■Non-Invasive Coronary Artery Imaging.
■Invasive Coronary Angiography.
■Coronary Artery Anomalies.
■Pathology of Chronic Obstructive Coronary Disease.
■Vulnerable Plaque.
■Genetics of Coronary Heart Disease.
■Endothelium Biology in Cardiovascular Disease.
■Stem Cells and Atherosclerosis.
■Induced Pluripotential Stem Cells and the Prospects for Cardiac Cell Therapy.
■Regulation of Vasculogenesis and Angionesis.
■Chronic Stable Angina.
■Pathology of Sudden Death in Coronary Arterial Diseases.
■Acute Coronary Syndrome.
■Complications of Acute Myocardial Infarction.
■Healed Myocardial Infarction.
■Non-Atherosclerotic Ischemic Heart Disease.
■Catheter Based Revascularization.
■Surgical Treatment of Coronary Artery Disease.
■Non-Coronary Surgical Therapy for Ischemic Heart Disease.
■Refractory Angina.
■Mechanical Circulatory Support and Vascular Remodeling: Acute Catheter Based Support.
■Mechanical Circulatory Support and Vascular Remodeling: Surgical VAD.
■Diabetes and Coronary Heart Disease.
■Cardiovascular Disease in Women
■Prevention of Atherosclerosis
■Emerging Technologies

 

Heart Failure. From Advanced Disease To Bereavement

http://www.librosdecardiologia.com/

Edición: 1ª
Autores: Miriam J Johnson; Karen Hogg; James Beattie
Editorial: Oxford University Press
ISBN: 9780199299300
Formato: Rústica/Paperback
Nº volumenes: 1 Páginas: 216
Año publicación: 2012
Disponibilidad: 15 días
Precio: 38,12 € (39,64€ iva incluído)

 

 

 

 

 

http://www.libreriasaulamedica.com/Heart-Failure.-From-Advanced-Disease-To-Bereavement_9780199299300_94946

 

 

About this Book
¡A succinct, concise, and user-friendly format facilitates quick acess to information access to information
¡A portable, practical, and accessible handbook on a complex issue
¡Written by experts in the fields of cardiology and palliative medicine
Excellent end of life care for people with heart failure is challenging but possible. Failure to address this aspect of care has serious consequences for patients, their families, clinicians and the use of health resources.

Heart Failure: From Advanced Disease to Bereavement illustrates the complexity and importance of end of life care for patients with advanced heart failure.

This book is a pocket reference for everyday use in the clinic, ward or home visit for all doctors, nurses and AHPs caring for people with advanced heart failure.

It outlines the underlying pathophysiology of heart failure, summarises standard pharmacological and device therapy, and sets the context of the challenges resulting from an unpredictable course of disease. In easily digestible summaries, this book presents practical advice about how and when to integrate a palliative care approach alongside standard heart failure management, how to communicate honestly in the face of uncertainty, the rationalisation of medication and device therapies at the end of life, symptom control, care for the dying, and care after death.

Readership: Professionals involved in cardiology, including doctors, nurses, and allied health professionals; palliative care specialist doctors, nurses and allied health professionals involved in the care of patients with cardiac disease, as well as specialist registrars

Table of Contents
1.The challenge of patients with heart failure: barriers in accessing supportive and palliative care
2.The physiology of patients with heart failure: the origin of symptoms and rationale for treatment
3.Prognostication and disease trajectory
4.Communication in heart failure
5.Diagnosing end stage heart disease
6.Integrating supportive and palliative care
7.Optimising management in end stage heart failure
8.Advance care planning
9.Management of pain
10.Symptoms other than pain
11.Psychological and psychosocial aspects of heart failure
12.Cardiopulmonary resuscitation and device therapy at the end of life
13.Care of the dying
14.Spiritualty and religious care
15.Supporting carers
About the Author
Miriam Johnson, Senior Lecturer in Palliative Medicine, Hull-York Medical School (HYMS) and Honorary Consultant in Palliative Medicine to St. Catherine's hospice, Scarborough and Scarborough and District NHS Trust, UK,
Karen Hogg, Consultant Cardiologist, Glasgow Royal Infirmary & Golden Jubilee National Hospital, UK,
James Beattie, Consultant Cardiologist, Birmingham Heartlands Hospital, UK

Edited by Max Watson, Belfast City Hospital (Research Fellow), Northern Ireland Hospice Care (Locum Consultant Palliative Medicine), UK

Contributors:

Dr Shona Jenkins SpR Cardiology Glasgow Royal Infirmary UK
Dr Suzanne Kite, MA FRCP Consultant in Palliative Medicine The Leeds Teaching Hospitals NHS Trust UK

Funcional Foods And Cardiovascular Disease

http://www.librosdecardiologia.com/

Edición: 1ª
Autores: Mohammed H. Moghadisian; Michael Eskin
Editorial: CRC PRESS
ISBN: 9781420071108
Formato: Rústica/Paperback
Nº volumenes: 1 Páginas: 296
Año publicación: 2012
Disponibilidad: 15 días
Precio: 112,09 € (116,57€ iva incluído)

 

 

 

 

http://www.libreriasaulamedica.com/Funcional-Foods-And-Cardiovascular-Disease_9781420071108_94767

 

 

 

Description

Drawn from the latest clinical and experimental information, this book covers cover products enriched with phytosterols, n-3 fatty acids, garlic extract naturally occurring antioxidants, folic acid, CLA, as well as fibers and flavonoids. It describes the connection between diets, dietary habits, and cardiovascular diseases. It also explains how functional food ingredients and nutraceuticals can mitigate cardiovascular disorders. The authors examine recent technologies for generating novel food products enriched with cardiovascular protective dietary agents. They include experimental and clinical evidence of various ingredients.

Table of Contents
¡Coronary Artery Disease: The Impact of Dietary Agents.
¡Advances in Food and Nutrition Technology to Generate Cardiovascular Friendly Food Products.
¡Experimental and Clinical Evidence of Cardiovascular Benefits of Plant Sterols.
¡N-3 Fatty Acids in Prevention of Cardiovascular Disease.
¡Folic Acid and Pathogenesis of Cardiovascular Disease.
¡Garlic Products in Reduction of Cardiovascular Risks.
¡Grapes and Wine And Cardiovascular Disease.
¡Nuts and Cardiovascular Risk Reduction.
¡Dairy and Soybean Products and Pathogenesis of Cardiovascular Disease.
¡The Impact of Egg Consumption in Development or Prevention of Heart Disease.
¡Oats, Fibers, and Psyllium for Treatment of Prevention of Cardiovascular Disease.
¡Cardiovascular Benefits of Tea, Coffee and Chocolate.
¡Natural Antioxidants and Other Ingredients from Berries for Prevention of Cardiovascular Benefits.

ECG Workout, Exercises In Arrhythmia Interpretation

http://www.librosdecardiologia.com/

Edición: 6ª
Autores: Jane Huff
Editorial: Lippincott Williams & Wilkins
ISBN: 9781451115536
Formato: Rústica/Paperback
Nº volumenes: 1 Páginas: 384
Año publicación: 2011
Disponibilidad: 15 días
Precio: 40,00 € 36,10 € (37,54€ iva incluído)

http://www.libreriasaulamedica.com/ECG-Workout-Exercises-In-Arrhythmia-Interpretation_9781451115536_92023

This outstanding text and workbook is the leading reference for students, practicing nurses, paramedics, and other health professionals learning ECG interpretation. Thoroughly updated with new figures and easy-to-follow text, ECG Workout is an excellent guide to rhythm analysis that builds on knowledge in a step-by-step fashion to broaden the understanding of essential ECG concepts and build the skills to confidently and accurately interpret ECG waveforms.

Get the knowledge you need to meet the challenges of ECG interpretation with:

Over 600 actual-sized practice rhythm strips – more than any other guide on the market!
Clear, thorough overviews of anatomy, physiology, and electrophysiology
Identification of principal waveform components and scores of illustrations for essential ECG concepts
Easy, five-step method for analyzing any rhythm strip
Chapters covering the most common arrhythmias, - sinus arrhythmias, atrial arrhythmias, junctional arrhythmias and AV blocks, ventricular arrhythmias and bundle-branch blocks, pacemakers – all with typical waveforms
Hardwire and telemetry monitoring equipment and troubleshooting tips
New! Skillbuilder section for extra practice differentiating among mixed strips
New! More glossary terms and 48 pull-out flashcards for self-testing
Plus …

Comprehensive post-test to evaluate what you’ve learned
Handy pocket ECG conversion card for more precise heart rate calculation
Online PowerPoint chapter reviews and flash cards (see inside cover for details)
FEATURES

All chapters thoroughly revised and updated
Step-by-step guide to rhythm strip analysis
NEW: Skill-building approach to learning, with new "Skill builder" practice rhythm strips in select chapters
—Chapter 7 (Atrial Arrhythmias) includes 25 mixed practice strips—sinus and atrial strips—helping students distinguish between the two types of rhythms
—Chapter 8 (Junctional Arrhythmias and AV Blocks) includes a mixture of additional practice strips—atrial, junctional, and heart block—building on information from the preceding chapter
—Chapter 9 (Ventricular Arrhythmias and Bundle Branch Blocks) goes one step further to include a mix of yet more practice strips—sinus, atrial, junctional, heart block, and ventricular—encouraging students to apply recently learned concepts and skills
NEW: Chapter 10 (Pacemakers) extensively revised to include permanent pacemaker strips and temporary venous strips
Bonus 48 perforated flash cards—with one side illustrating an ECG strip, the reverse side identifing the waveform and detailing its defining ECG characteristics (rhythm interpretation, rate, P waves, PR interval, and QRS complex)
Latest ACLS guidelines provided
End-of-chapter practice rhythm strips with corresponding answer keys at the back of the book
Posttest featuring over 100 waveform rhythm strips
Updated Glossary with terms highlighted at first mention in text
Simple, easy-to-follow text with hundreds of figures, including anatomical drawings, sample waveform configurations, and real-sized ECG strips
TABLE OF CONTENTS

Preface

Anatomy and physiology of the heart
Electrophysiology
Waveforms, intervals, segments, and complexes
Cardiac monitors
Analyzing a rhythm strip
Sinus arrhythmias
Atrial arrhythmias
Junctional arrhythmias and AV blocks
Ventricular arrhythmias and bundle-branch block
Pacemakers
Posttest Appendices --Answer keys to Practice strips and Skill-building strips
--Glossary --
Electrocardiographic conversion table for heart rate
Pull-out
Arrhythmias flash cards

AUTHOR

Jane Huff RN, CCRN
Education Coordinator, Critical Care Unit, Arrhythmia Instructor, Advanced Cardiac Life Support (ACLS) Instructor, White County Medical Center, Searcy, AR

Electrocardiógrafo Fukuda FX7202 3/6 canales con acumulador recargable

http://www.librosdecardiologia.com/

Fabricante: Fukuda

Ref: ECFX720200
Disponibilidad: Inmediata
Precio: 1510,50 € 1358,00 € (1466,64€ iva incluído)

 

 

 

 

 

 

 

 

 

http://www.libreriasaulamedica.com/Electrocardiografo-Fukuda-FX7202-36-canales-con-acumulador-recargable_01045386129014542150001814_90985

 

 

 

 

Cardiógrafo de 6 canales automático o manual con acumulador recargable incorporado y a red, 4 velociodades (10 , 12.5 , 50 mm /seg) 4 sensibilidades ( 0.25 ,0.5.1 y 2cm /mV), 5 filtros anchura de papel de 110 mm, con pantalla táctil LCD ( 320 *240 ) para visulización en tiempo real de 3 , 6 o 12 canales , imcluye teclado alfanumérico completo , memoria para mínimo 128 mediciones , puerto LAN para comunicación en redes informáticas, con accesorios y manual de usuario en cast

Mejora de la calidad de la asistencia en el infarto agudo de miocardio: es necesario prestar mayor atención al tratamiento médico óptimo a largo plazo y a la prevención secundaria

http://www.librosdecardiologia.com/

La reperfusión rápida, junto con la aspiración del trombo e implantación de stents coronarios, acompañada de un tratamiento adyuvante antiagregante plaquetario y antitrombótico potente, ha modificado drásticamente la evolución clínica del infarto agudo de miocardio con elevación del ST (IAMCEST). Desde que a comienzos de los años setenta¹ se describiera el concepto de limitar el tamaño del infarto de miocardio mediante reperfusión miocárdica inmediata, la mortalidad intrahospitalaria del IAMCEST se ha reducido de un 30% a números de una sola cifra en los últimos ensayos clínicos de la reperfusión².

Aunque la mortalidad de las enfermedades cardiovasculares se ha reducido a la mitad en los últimos 50 años³, sigue siendo la principal causa de muerte en los países desarrollados^{4, 5}. Además, durante las próximas décadas, las autoridades sanitarias tendrán que enfrentarse a un reto enorme, con el aumento progresivo y sustancial de la prevalencia y los costes de la enfermedad cardiovascular como consecuencia del envejecimiento de la población⁶.

Mediante el empleo de una base de datos administrativa sobre altas hospitalarias, Andrés et al⁷, en su artículo publicado en Revista Española de Cardiología , analizan los resultados a largo plazo obtenidos en el infarto agudo de miocardio en Aragón entre 2000 y 2007. Su análisis pone de manifiesto que los reingresos por infarto agudo de miocardio recurrente son muy frecuentes: se registró un reingreso debido a un nuevo infarto agudo de miocardio en el 44,2% de los pacientes de 45 a 65 años durante el primer año y en el 73,9% a los 3 años del alta hospitalaria. Esta alta tasa de recurrencia concuerda con las observaciones realizadas en otros registros^{8, 9, 10}: el tratamiento moderno de los síndromes coronarios agudos ha producido una notable mejora de los resultados clínicos intrahospitalarios, pero la carga de morbimortalidad durante el seguimiento inmediato y tardío es casi 3 o 4 veces superior al existente durante la hospitalización inicial. Además, el riesgo de eventos cardiovasculares recurrentes y de mortalidad durante el seguimiento a largo plazo es mayor en los pacientes con síndromes coronarios agudos sin elevación del ST en comparación con los pacientes con IAMCEST, cosa que no se había identificado hasta hace poco. Así pues, si queremos mejorar la calidad de la asistencia de los síndromes coronarios agudos, deberemos centrarnos más en la prevención de los eventos cardiovasculares recurrentes y de la mortalidad durante el seguimiento inicial y a largo plazo.

¿Cómo podemos hacerlo? En primer lugar realizando una revascularización coronaria más completa en los pacientes con IAMCEST que presentan una enfermedad coronaria en múltiples vasos. En comparación con la angioplastia realizada solamente en el vaso «culpable», la revascularización de múltiples vasos en los pacientes con IAMCEST se asoció a una reducción notable de los eventos adversos cardiacos mayores durante el seguimiento a largo plazo¹¹. En las lesiones «no culpables», si se demuestra que son significativas mediante la determinación de la reserva de flujo fraccional, probablemente lo mejor sea tratarlas mediante intervención coronaria percutánea o cirugía de revascularización aortocoronaria, en distintos momentos, ya sea durante la hospitalización inicial o poco después de ella, en lugar de hacer una intervención coronaria percutánea sobre múltiples vasos en la fase aguda del ingreso^{12, 13, 14, 15}.

Además, en los pacientes con una enfermedad cardiovascular preexistente, los diabéticos y los que tienen un número elevado de factores de riesgo cardiovascular, debemos estar muy atentos a la aplicación de un tratamiento médico óptimo y las medidas de prevención secundaria. La observación de Andrés et al⁷ de que el número de factores de riesgo cardiovascular presentes es un importante factor que determina reingreso y mortalidad durante el seguimiento a largo plazo, resalta nuevamente la importancia de incluir la rehabilitación cardiaca y otras medidas de prevención secundaria, además de la reperfusión, en las actuaciones combinadas que se utilizan para evaluar la calidad de la asistencia al IAMCEST¹⁶.

El importante papel de los factores de riesgo cardiovascular, como elementos determinantes de los eventos cardiacos recurrentes tras un infarto de miocardio, concuerda también con la observación de que más de la mitad de la reducción de la mortalidad cardiovascular observada en los países desarrollados durante los últimos 50 años ha estado relacionada con la mejora de la prevención cardiovascular y con una mejor aplicación de los tratamientos médicos eficaces, más que con nuevas intervenciones terapéuticas tecnológicas¹⁷. El envejecimiento de la población llevará en un futuro próximo a un importante aumento de la necesidad de hospitalizaciones de pacientes por síndromes cardiovasculares agudos. Así pues, cualquier reducción que se consiga en la necesidad de rehospitalización tras un primer infarto agudo de miocardio mediante una prevención secundaria más efectiva de la enfermedad coronaria será más que bien recibida.

Por último, la observación de que un gran número de rehospitalizaciones se producen mucho después del periodo habitual de 12 meses de duración de un ensayo clínico aleatorizado resalta el importante papel complementario de los estudios observacionales y los registros a largo plazo en la evaluación de la eficacia de las nuevas modalidades terapéuticas o fármacos para la prevención secundaria tras el síndrome coronario agudo¹⁸.

Conflicto de intereses

Ninguno.

Full English text available from: http://www.revespcardiol.org/

Autor para correspondencia: Department of Cardiology, Antwerp University Hospital, Wilrijkstraat 10, B-2650 Edegem, Bélgica. christiaan.vrints@ua.ac.be

Bibliografía

1.Maroko PR, Kjekshus JK, Sobel BE, Watanabe T, Covell JW, Ross J, et-al. Factors influencing infarct size following experimental coronary artery occlusions. Circulation. 1971; 43:67-82.

Pubmed

2. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet. 2006;367:569–78.

3.Kesteloot H, Sans S, Kromhout D. Dynamics of cardiovascular and all-cause mortality in Western and Eastern Europe between 1970 and 2000. Eur Heart J. 2006; 27:107-13.

Pubmed

4.Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et-al. Heart disease and stroke statistics —2011 update: a report from the American Heart Association. Circulation. 2011; 123:e18-e209.

Pubmed

5.Allender S, Scarborough P, Peto V, Rayner M, Leal J, Luengo-Fernandez R, et-al. European cardiovascular disease statistics. Londres: British Heart Foundation; 2008.

6.Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, et-al. Forecasting the future of cardiovascular disease in the United States. Circulation. 2011; 123:933-44.

Pubmed

7.Andrés E, Cordero A, Magán P, Alegría E, León M, Luengo E, et-al. Mortalidad a largo plazo y reingreso hospitalario tras infarto agudo de miocardio: un estudio de seguimiento de ocho años. Rev Esp Cardiol. 2012; 65:414-20.

8.Fox KA, Carruthers KF, Dunbar DR, Graham C, Manning JR, De Raedt H, et-al. Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study). Eur Heart J. 2010; 31:2755-64.

Pubmed

9.Garcia-Garcia C, Subirana I, Sala J, Bruguera J, Sanz G, Valle V, et-al. Long-term prognosis of first myocardial infarction according to the electrocardiographic pattern (ST elevation myocardial infarction, non-ST elevation myocardial infarction and non-classified myocardial infarction) and revascularization procedures. Am J Cardiol. 2011; 108:1061-7.

Pubmed

10.Polonski L, Gasior M, Gierlotka M, Osadnik T, Kalarus Z, Trusz-Gluza M, et-al. A comparison of ST elevation versus non-ST elevation myocardial infarction outcomes in a large registry database: are non-ST myocardial infarctions associated with worse long-term prognoses?. Int J Cardiol. 2011; 152:70-7.

Pubmed

11.Politi L, Sgura F, Rossi R, Monopoli D, Guerri E, Leuzzi C, et-al. A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up. Heart. 2010; 96:662-7.

Pubmed

12.Widimsky P, Holmes DR. How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease?. Eur Heart J. 2011; 32:396-403.

Pubmed

13.Vlaar PJ, Mahmoud KD, Holmes DR, Van Valkenhoef G, Hillege HL, Van der Horst ICC, et-al. Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis. J Am Coll Cardiol. 2011; 58:692-703.

Pubmed

14.Kornowski R, Mehran R, Dangas G, Nikolsky E, Assali A, Claessen BE, et-al. Prognostic impact of staged versus “one-time” multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol. 2011; 58:704-11.

Pubmed

15.Bittl JA. Interventional strategies for ST-segment elevation myocardial infarction and multivessel coronary artery disease. J Am Coll Cardiol. 2011; 58:712-4.

Pubmed

16.Krumholz HM, Anderson JL, Bachelder BL, Fesmire FM, Fihn SD, Foody JM, et-al. ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for ST-Elevation and Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American Academy of Family Physicians and American College of Emergency Physicians Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Cardiovascular Angiography and Interventions, and Society of Hospital Medicine. J Am Coll Cardiol. 2008; 52:2046-99.

Pubmed

17.Björck L, Rosengren A, Bennett K, Lappas G, Capewell S. Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. Eur Heart J. 2009; 30:1046-56.

Pubmed

18.Bueno Hc , Armstrong PW, Buxton MJ, Danchin N, Lubsen J, Roland E, et-al. The future of clinical trials in secondary prevention after acute coronary syndromes. Eur Heart J. 2011; 32:1583-9.

Pubmed

• Contenidos relacionados

• • Artículos publicados por:
    • Christiaan J.M. Vrints
  • Artículos relacionados:
    • Mortalidad a largo plazo y reingreso hospitalario tras infarto agudo de miocardio: un estudio de seguimiento de ocho años
  • Buscar este artículo en PubMed
  • Artículos similares en PubMed

Fuente:

http://www.revespcardiol.org/es/revistas/revista-espa%C3%B1ola-cardiologia-25/mejora-calidad-asistencia-infarto-agudo-miocardio-es-90123823-editoriales-2012

ECG Interpretation For Everyone. An On-The-Spot Guide

http://www.librosdecardiologia.com/

Edición: 1ª
Autores: Fred Kusumoto
Editorial: Wiley
ISBN: 9780470655566
Formato: Rústica/Paperback
Nº volumenes: 1 Páginas: 508
Año publicación: 2012
Disponibilidad: 15 días
Precio: 26,85 € (27,92€ iva incluído)
 

http://www.libreriasaulamedica.com/ECG-Interpretation-For-Everyone.-An-OnTheSpot-Guide_9780470655566_94460

This is a book for any care provider - from advanced students and nurses to residents and even specialists - who needs to master the interpretation of ECGs, especially while "on the spot" at the point of care. This easy-to-use, visual guide takes a novel approach, foregrounding the visual clues or "keys" that readers can learn to recognize in ECGs and thus make rapid decisions about next steps at the point of care. The comparatively minimal text focuses on "must-know" information about the underlying cause of ECG abnormalities.

Ambulatory Impedance Cardiography

http://www.librosdecardiologia.com/

Edición: 1ª
Autores: Cybulski, Gerard
Editorial: Springer
ISBN: 9783642119866
Formato: Tapa Dura/Hardback
Nº volumenes: 1 Páginas: 150
Año publicación: 2011
Disponibilidad: 15 días
Precio: 89,96 € (93,55€ iva incluído)

http://www.libreriasaulamedica.com/Ambulatory-Impedance-Cardiography_9783642119866_72062

”Ambulatory Impedance Cardiography” gives the reader the necessary physical background of impedance cardiography (ICG) and currently available systems for hemodynamics holter monitoring. It compares ambulatory ICG and other clinically accepted methods through an updated state-of-the-art. The book is divided in 4 parts. In the first one, the importance of the analysis of the cardiac dynamics using the ambulatory monitoring technique is presented. The second part contains the description of foundations of ICG, the models used to describe the ICG technique and the description of available systems for ambulatory monitoring of cardiac hemodynamics. The third part is devoted to the validation of the ambulatory ICG method, the verification of the quality of long term ICG recordings and the discussion of the limitations of this technique. In the last part, some clinical and research applications of the ICG ambulatory monitoring are presented.

Content Level » Research

Keywords » AICG - artial fibrillation - cardiac dsp - cardiac haemodynamics - cardiac parametrs - holter - noninvasive method - tilt text

Related subjects » Biomedical Engineering - Biophysics & Biological Physics - Cardiology & Angiology

 

Clinical Electrocardiography. A Textbook 4th Ed.

http://www.librosdecardiologia.com/

Edición: 4ª
Autores: Antoni Bayés de Luna
Editorial: Wiley
ISBN: 9780470658598
Formato: Rústica/Paperback
Nº volumenes: 1 Páginas: 568
Año publicación: 2012
Disponibilidad: 15 días
Precio: 95,96 € (99,80€ iva incluído)
 

 

 

 

 

http://www.libreriasaulamedica.com/Clinical-Electrocardiography.-A-Textbook-4th-Ed._9780470658598_270529

 

 

Description
Written by one of the world's most respected cardiologists and designed with the needs of the internist and general clinical cardiologist in mind, this new volume provides clear, accessible guidance on the use of electrocardiography to diagnose and manage cardiovascular disease.

Table of Contents
¡Preface,
¡Foreword by Dr Eugene Braunwald,
¡Foreword by Dr Marcelo Elizari,
¡Recommended Reading,
¡Part 1 Introductory Aspects
¡1. The Electrical Activity of the Heart,
¡2. The History of Electrocardiography,
¡3. Utility and Limitations of the Surface ECG: Present and Future,
¡Part 2 The Normal ECG
¡4. The Anatomical Basis of the ECG: From Macroscopic Anatomy to Ultrastructural Characteristics,
¡5. The Electrophysiological Basis of the ECG: From Cell Electrophysiology to the Human ECG,
¡6. The ECG Recording: Leads, Devices, and Techniques,
¡7. Characteristics of the Normal Electrocardiogram: Normal ECG Waves and Intervals,
¡8. Diagnostic Criteria: Sensitivity, Specificity and Predictive Value,
¡Part 3 Abnormal ECG Patterns
¡9. Atrial Abnormalities,
¡10. Ventricular Enlargement,
¡11. Ventricular Blocks,
¡12. Ventricular Pre-excitation,
¡13. Ischemia and Necrosis,
¡Part 4 Arrhythmias
¡14. Mechanisms, Classification, and Clinical Aspects of Arrhythmias,
¡15. Active Supraventricular Arrhythmias,
¡16. Active Ventricular Arrhythmias,
¡17. Passive Arrhythmias,
¡18. Diagnosis of Arrhythmias in Clinical Practice: A Step-by-Step Approach,
¡Part 5 The Clinical Usefulness of Electrocardiography
¡19. The Diagnostic Value of Electrocardiographic Abnormalities,
¡20. The ECG in Different Clinical Settings of Ischemic Heart Disease,
¡21. Inherited Heart Diseases,
¡22. The ECG in Other Heart Diseases,
¡23. The ECG in Other Diseases and Different Situations,
¡24. Other ECG Patterns of Risk,
¡25. Limitations of the Conventional ECG: Utility of Other Techniques,